Novavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic ...
23 hours ago · Novavax Inc (NASDAQ:NVAX) has established a strategic partnership with Sanofi, which will lead to double-digit royalties from Sanofi's sales of the COVID-19 vaccine starting in 2025.
Novavax Q3 Earnings & Sales Beat, Stock Falls 6% on '24 View Cut
More on NVAX’s Earnings. Novavax recorded $38.2 million in product sales compared with $2.2 million in the year-ago quarter. This upside was primarily driven by sales of the company’s protein ...
FDA clears Novavax to resume trials of Covid-19 and flu combo …
1 day ago · In response to these challenges, Novavax has undertaken significant financial restructuring, with plans to cap combined R&D and SG&A spending below $500m in 2025 and under $350m by 2026, as per ...
Novavax Advances Vaccine Strategy Amid Financial Shifts
1 day ago · Novavax ( (NVAX)) has released its Q3 earnings. Here is a breakdown of the information Novavax presented to its investors. Novavax, Inc., based in Gaithersburg, Maryland, is a global biotechnology ...
Novavax Reports Third Quarter 2024 Financial Results and …
1 day ago · Achieved total revenue of $85 million in the third quarter of 2024. Ended the third quarter of 2024 with $1 billion in cash and receivables. Received authorization from U.S. FDA and European ...
U.S. FDA Removes Clinical Hold on Novavax's COVID-19 …
2 days ago · About Novavax Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to help protect against serious infectious diseases.
Novavax's Updated Protein-based COVID-19 Vaccine Now an …
GAITHERSBURG, Md., Nov. 28, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that Nuvaxovid™ XBB.1.5 COVID-19 Vaccine (NVX-CoV2601) has been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunization to ...
Novavax Presents Data on Updated COVID-19 Vaccine and …
Apr 1, 2024 · New data from Novavax's ongoing research on its updated XBB.1.5 COVID-19 vaccine in participants who previously received an mRNA vaccine showed robust neutralizing antibody titers for the XBB.1.5 subvariant as well as for the currently circulating JN.1 subvariant.
Novavax: FDA removes clinical hold on Covid-19/flu combo trial
3 days ago · Nov. 11, 2024, 07:35 AM. Novavax (NVAX) announced that the U.S. FDA has removed the clinical hold on Novavax’s Investigational New Drug application for its COVID-19-Influenza Combination and ...
FDA authorizes Novavax's updated Covid vaccine - NBC News
Oct 3, 2023 · The Food and Drug Administration on Tuesday authorized an updated version of Novavax's Covid vaccine, allowing doses to begin shipping to doctors' offices and pharmacies across the country.
- Some results have been removed